Bengaluru, India

Akella Venkateswarlu

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beckman Corporation. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akella Venkateswarlu. Retrieved from https://idiyas.com/inventor/akella-venkateswarlu-e0ercabc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akella Venkateswarlu: Innovator in Glycopeptide Antibiotics

Introduction

Akella Venkateswarlu is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of antibiotics, particularly through his innovative work on glycopeptide antibiotics.

Latest Patents

Venkateswarlu holds a patent for novel glycopeptide antibiotics derived from the CWI-785 complex, produced by the Actinomycete SKF-CWI-785. This patent represents a significant advancement in antibiotic development, showcasing his expertise and dedication to improving healthcare.

Career Highlights

He is currently associated with SmithKline Beecham Corporation, where he continues to work on groundbreaking research in pharmaceuticals. His career is marked by a commitment to innovation and excellence in the field of microbiology and antibiotic research.

Collaborations

Throughout his career, Venkateswarlu has collaborated with esteemed colleagues, including Ashok K Verma and Anil K Goel. These partnerships have fostered a collaborative environment that enhances the research and development of new antibiotics.

Conclusion

Akella Venkateswarlu's contributions to the field of glycopeptide antibiotics highlight his role as a leading inventor in pharmaceutical innovation. His work continues to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…